Organisation paid for research Program year 2025 Source: CMS Open Payments

Honorhealth

Neither a doctor nor a teaching hospital

Research payments

$1,070,896

185 payments

Through program year 2025, Honorhealth is reported as receiving $1,070,896 in research payments, across 185 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$138,897	29
2024	Research	$368,781	70
2023	Research	$194,560	30
2022	Research	$98,214	29
2021	Research	$141,727	16
2020	Research	$123,858	9
2019	Research	$4,860	2

Breakdown

Who paid Research payments · program years 2019–2025

Janssen Research & Development, LLC $279,549 51 payments
Medtronic, Inc. $161,167 17 payments
Medtronic Vascular, Inc. $115,078 9 payments
AngioDynamics, Inc. $90,427 6 payments
GlaxoSmithKline, LLC. $87,452 39 payments
Pfizer Inc. $77,615 4 payments
Alexion Pharmaceuticals, Inc. $56,850 3 payments
Daiichi Sankyo Inc. $53,364 8 payments
Otsuka Pharmaceutical Co., Ltd. $49,391 12 payments
Deciphera Pharmaceuticals Inc. $37,133 14 payments

Studies the money was for Research payments · program years 2019–2025

70033093Afl3002 $193,021 30 payments
Spyral Htn-Off Med $148,130 16 payments
Spyral Affirm $106,635 2 payments
A Phase 1 Dose Escalation and Expansion Study Evaluating Safety Tolerability and Pharmacokinetics of PF 06952229 in Adult Patients With Advanced Solid Tumors $76,104 1 payment
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Gr $65,615 26 payments
Pl3397-A-U4003 $53,364 8 payments
70033093Acs3003 $52,373 18 payments
Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism (APEX-AV) $50,169 3 payments
A Phase 1 Study of Safety, Pharmacokinetics and Preliminary Activity of Tas1553 in Subjects With Replaced Or Refractory (R/R) Acute Myeloid Leukemia (Aml) and Other Myeloid Neoplasms $45,358 10 payments
Apex $40,258 3 payments

What the money was spent on Research payments · program years 2019–2025

Other $90,427 6 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.